Churchill Downs Incorporated
CHDN
$89.77
+2.94%
Churchill Downs Incorporated is a diversified gaming and racing company operating in the Consumer Cyclical sector, specifically within Gambling, Resorts & Casinos. Its core business spans three segments: Live and Historical Racing, which includes the iconic Kentucky Derby; Wagering Services through its TwinSpires platform; and Gaming, encompassing casino properties and associated racetracks. The company is a market leader in premier racing events and a significant player in regional gaming and online wagering. The current investor narrative is heavily focused on strategic expansion, particularly highlighted by its recent definitive agreement to acquire the Preakness Stakes intellectual property rights, which aims to solidify its portfolio of marquee racing assets and create a new, stable revenue stream, positioning the company for long-term growth beyond its flagship Kentucky Derby event.…
CHDN
Churchill Downs Incorporated
$89.77
Related headlines
Investment Opinion: Should I buy CHDN Today?
Rating & Thesis: The stock is a Hold. The core thesis is that while the forward valuation is compelling and cash generation is strong, significant financial leverage and persistent technical weakness create too much near-term risk to warrant a Buy rating, despite bullish analyst sentiment from a handful of firms.
Supporting Evidence: The primary valuation metric, the forward P/E of 12.00x, is attractive and implies a significant earnings recovery from the recent quarterly EPS of $0.71 to the consensus $7.40. The company generates substantial free cash flow ($605M TTM) and a high ROE of 37.61%, demonstrating underlying business strength. However, revenue growth is modest at 6.68% YoY, profitability is volatile (net margin range of 5.55%-23.21%), and the stock trades near its 52-week low, reflecting deep negative sentiment and no technical support for a rally.
Risks & Conditions: The two biggest risks are the high debt-to-equity ratio (5.15) and the accelerating price decline with no visible catalyst for reversal. This Hold would upgrade to a Buy if the stock stabilizes above its 52-week low and the company demonstrates progress in de-leveraging its balance sheet while meeting quarterly earnings milestones. It would downgrade to a Sell if it breaches the $80.24 support level or if forward EPS estimates begin to be revised downward. Relative to its own historical P/E range, the stock appears undervalued, but it is fairly valued given the elevated financial and operational risks.
Sign up to view all
CHDN 12-Month Price Forecast
The assessment is neutral with medium confidence. The valuation is compelling on a forward basis, and the company's cash generation is robust. However, the high financial leverage and the stock's persistent technical weakness are significant headwinds. The market is pricing in a successful earnings rebound that carries execution risk. The stance would upgrade to bullish on evidence of debt reduction and sustained technical support above $85, while a break below $80 or a cut to forward EPS estimates would warrant a bearish view.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Churchill Downs Incorporated's 12-month outlook, with a consensus price target around $116.70 and implied upside of +30.0% versus the current price.
Average Target
$116.70
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$72 - $117
Analyst target range
Analyst coverage for CHDN is limited, with only four analysts providing estimates for revenue and EPS, indicating this is a stock with less institutional scrutiny which can lead to higher volatility and less efficient price discovery. The consensus estimates point to expected revenue of $3.25 billion and EPS of $7.40 for the period ahead, but specific price targets, a consensus recommendation, and a Buy/Hold/Sell distribution are not provided in the data, preventing calculation of implied upside or downside. The available institutional ratings from the past year show a pattern of reiterated bullish stances from firms like Wells Fargo, Barclays, and JP Morgan, all maintaining 'Overweight' or equivalent ratings, which suggests underlying analyst confidence in the company's strategy despite the stock's poor price performance; however, the absence of concrete price targets and the low analyst count mean the signal strength of this sentiment is muted, and investors must rely more on fundamental and technical analysis for conviction.
Bulls vs Bears: CHDN Investment Factors
The evidence is currently balanced but tilts bearish due to the stock's persistent technical breakdown and high financial leverage, which overshadow its strong cash generation and attractive forward valuation. The bull case hinges on the forward P/E of 12x materializing through a successful earnings recovery and strategic integration of the Preakness acquisition. The bear case is driven by the accelerating price decline, weak liquidity, and earnings volatility. The single most important tension in the investment debate is whether the company's robust cash flow and strategic expansion can overcome its heavy debt burden and seasonal earnings profile to justify the market's expectation of a near-doubling of earnings implied by the forward P/E.
Bullish
- Strong Cash Flow and ROE: The company generates robust free cash flow of $605 million (TTM) and delivers a high Return on Equity of 37.61%. This demonstrates the core business's ability to generate shareholder value and fund its operations and debt service internally.
- Significant Forward P/E Compression: The stock trades at a forward P/E of 12.00x, which is a steep discount to its trailing P/E of 21.23x. This implies the market expects a substantial earnings recovery, with analyst consensus pointing to forward EPS of $7.40, suggesting strong future profitability.
- Strategic Asset Acquisition: The recent definitive agreement to acquire the Preakness Stakes intellectual property rights strengthens its portfolio of premier racing assets. This acquisition is aimed at creating a new, stable revenue stream, reducing reliance on the single Kentucky Derby event.
- Deeply Oversold Technicals: Trading at $87.21, the stock is near the bottom of its 52-week range, only 22.8% above its low of $80.24 and significantly below its high of $118.46. This deep oversold condition, with a max drawdown of -29.36%, may present a contrarian value opportunity.
Bearish
- High Financial Leverage and Weak Liquidity: The company's balance sheet is highly leveraged, with a debt-to-equity ratio of 5.15. Coupled with a weak current ratio of 0.60, this indicates significant financial risk and limited short-term liquidity to weather operational downturns.
- Severe Price and Relative Underperformance: The stock is down 20.06% over six months and 8.21% over one year, dramatically underperforming the S&P 500's gains of 10.7% and 28.21%, respectively. The -20.09 one-month relative strength confirms the downtrend is accelerating with no sign of reversal.
- Volatile and Seasonal Profitability: Profitability is highly inconsistent, with net margin swinging from 23.21% in Q2 2025 to 5.55% in Q3 2025. This volatility, tied to major racing events, makes earnings difficult to predict and suggests a lack of stable, recurring income streams.
- Limited Analyst Coverage and No Price Targets: Only four analysts provide estimates, and no consensus price target or recommendation is available. This low coverage leads to less efficient price discovery and higher volatility, as the market lacks a clear valuation anchor from the sell-side.
CHDN Technical Analysis
The stock is in a pronounced downtrend, having declined 20.06% over the past six months and 8.21% over the past year, significantly underperforming the broader market which gained 28.21% over the same one-year period. With a current price of $87.21, the stock is trading at approximately 22.8% of its 52-week range, positioned much closer to its 52-week low of $80.24 than its high of $118.46, indicating deep oversold conditions that may present a value opportunity but also reflect persistent negative sentiment and fundamental concerns. Recent momentum remains weak, with the stock down 13.78% over the past month and 5.13% over the past three months, both figures starkly contrasting with the S&P 500's gains of 6.31% and 10.28%, respectively, over the same periods; this persistent underperformance, evidenced by a -20.09 relative strength over one month, suggests the downtrend is accelerating with no signs of a near-term reversal. Key technical support is clearly defined at the 52-week low of $80.24, while resistance sits near the 52-week high of $118.46; a breakdown below $80.24 could trigger a new leg down, whereas any recovery would need to contend with significant overhead supply. The stock's beta of 0.73 indicates it is 27% less volatile than the market, which, combined with a max drawdown of -29.36%, suggests it has exhibited defensive characteristics during its decline but remains susceptible to company-specific risks.
Beta
0.73
0.73x market volatility
Max Drawdown
-29.4%
Largest decline past year
52-Week Range
$80-$118
Price range past year
Annual Return
-6.0%
Cumulative gain past year
| Period | CHDN Return | S&P 500 |
|---|---|---|
| 1m | -9.0% | +5.3% |
| 3m | -3.9% | +11.5% |
| 6m | -19.6% | +10.9% |
| 1y | -6.0% | +28.7% |
| ytd | -19.8% | +11.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CHDN Fundamental Analysis
Revenue growth has been modest but positive, with Q4 2025 revenue of $665.9 million representing a 6.68% year-over-year increase; however, examining the quarterly trend from the income statements reveals volatility, with revenue peaking at $934.4 million in Q2 2025 before declining sequentially, indicating potential seasonality tied to major racing events rather than consistent organic acceleration. The company is profitable, posting Q4 2025 net income of $49.8 million and a trailing twelve-month net margin of 12.98%, but profitability is inconsistent, as evidenced by a net margin that ranged from 5.55% in Q3 2025 to 23.21% in Q2 2025; gross margin for Q4 2025 was 29.54%, which is below the full-year gross margin of 33.58% from valuation data, suggesting some quarterly compression, potentially due to mix or promotional activity. Financial health is a concern due to a highly leveraged balance sheet, with a debt-to-equity ratio of 5.15 and a current ratio of 0.60, indicating limited short-term liquidity; however, the company generates substantial cash flow, with free cash flow over the trailing twelve months at $605 million and an ROE of 37.61%, demonstrating it can service its debt and fund operations internally, though the high leverage amplifies financial risk in a downturn.
Quarterly Revenue
$665900000.0B
2025-12
Revenue YoY Growth
+0.06%
YoY Comparison
Gross Margin
+0.29%
Latest Quarter
Free Cash Flow
$605000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CHDN Overvalued?
Given a positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 21.23x and a forward PE of 12.00x based on estimated EPS. The significant gap between the trailing and forward multiples implies the market expects a substantial recovery in earnings, with forward estimates projecting EPS to rise sharply from the recent quarterly figure of $0.71. Peer comparison data is not available in the provided dataset, so a sector-relative premium or discount cannot be quantified. Comparing the current trailing PE of 21.23x to its own historical range reveals it is near the lower end; for instance, historical ratios show the PE was 40.78x at the end of Q4 2025 and has been as high as 1987x in late 2022 during an earnings trough. Trading near the bottom of its historical PE band suggests the market has priced in significant pessimism, potentially creating a value opportunity if the company's earnings stabilize or grow as forecasted.
PE
21.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 5x~1988x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary risk is the company's highly leveraged balance sheet, with a debt-to-equity ratio of 5.15, which amplifies financial risk in a downturn. Short-term liquidity is also a concern, with a current ratio of 0.60 indicating potential strain in meeting immediate obligations. Furthermore, earnings are highly volatile and seasonal, with net margin swinging from 5.55% to 23.21% across recent quarters, creating uncertainty for investors and complicating valuation. The company's dependence on a few marquee racing events for peak profitability, rather than stable recurring revenue, adds operational risk.
Market & Competitive Risks: The stock faces significant valuation compression risk, having already declined 20% over six months, but remains vulnerable if earnings fail to meet the high expectations embedded in its forward P/E of 12x. With a beta of 0.73, it is less correlated to the broader market, but this has not protected it from company-specific selling pressure, as evidenced by its -36.4% one-year relative strength versus the S&P 500. The gambling and resorts sector is sensitive to consumer discretionary spending and regulatory changes, and the low analyst count (4) contributes to higher volatility and less efficient price discovery.
Worst-Case Scenario: The worst-case scenario involves a continued deterioration in consumer spending, leading to a miss on forward EPS estimates of $7.40, coupled with rising interest rates increasing the cost of servicing its high debt load. This could trigger a liquidity crisis given the weak current ratio, forcing asset sales or dilutive equity raises. In this adverse scenario, the stock could re-test and break its 52-week low of $80.24, representing a downside of approximately -8% from the current price of $87.21. A more severe bear case, aligned with the stock's historical max drawdown of -29.36%, could see the price fall towards $62, representing a potential loss of -29%.
FAQ
The key risks are, in order of severity: 1) Financial Risk: Extremely high leverage with a debt-to-equity ratio of 5.15 and weak short-term liquidity (Current Ratio 0.60). 2) Operational Risk: Highly volatile and seasonal profitability, with net margin swinging from 5.55% to 23.21% across quarters, creating earnings uncertainty. 3) Market Risk: The stock is in a severe downtrend, underperforming the S&P 500 by over 36% in the past year, with no technical confirmation of a bottom. 4) Execution Risk: The success of the forward P/E multiple hinges on the company meeting aggressive EPS estimates of $7.40 and successfully integrating the Preakness acquisition.
The 12-month forecast is bifurcated, with a base case target range of $95-$110 (55% probability), a bull case of $118-$130 (25% probability), and a bear case of $70-$80 (20% probability). The base case, which is most likely, assumes the company meets forward EPS estimates of $7.40, leading to a gradual re-rating from the current depressed price. The key assumption is that earnings stabilize and grow modestly, allowing the stock to recover from deeply oversold conditions. The wide range reflects the high uncertainty stemming from the company's leverage and the market's current negative sentiment.
Based on forward earnings, CHDN appears undervalued. It trades at a forward P/E of 12.00x, which is a significant discount to its trailing P/E of 21.23x and suggests the market expects a major earnings recovery. However, this valuation is fair when accounting for the company's substantial risks. The high financial leverage (Debt/Equity of 5.15) and volatile, seasonal earnings profile justify a discount. The current price near its 52-week low also suggests the market has priced in significant pessimism. The valuation implies the market expects the company to nearly double its profitability from recent quarterly levels, which is a high bar.
CHDN presents a high-risk, high-potential-reward opportunity that is not a good buy for all investors. For value investors comfortable with leverage and volatility, the forward P/E of 12x and strong free cash flow ($605M TTM) are attractive. However, the stock is in a clear downtrend, down 20% in six months, and carries significant balance sheet risk with a debt-to-equity ratio of 5.15. It could be a good buy for a speculative portion of a portfolio if purchased near the $80 support level, but investors should be prepared for further volatility and have a long-term horizon.
CHDN is unsuitable for short-term trading due to its high volatility, low analyst coverage, and lack of a clear near-term catalyst to reverse its downtrend. It is best considered a long-term, contrarian value investment with a minimum holding period of 2-3 years. This timeframe allows for the potential execution of the company's strategic plan, including the Preakness integration and debt management, and for the forward earnings story to play out. The stock's beta of 0.73 suggests it is less volatile than the market, but its company-specific risks and seasonal earnings profile require patience.